CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 173 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $144,000 | +12.5% | 5,874 | -18.3% | 0.00% | – |
| Q4 2018 | $128,000 | – | 7,188 | +37731.6% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 19 | -98.4% | 0.00% | – |
| Q2 2018 | $54,000 | -71.9% | 1,185 | -67.3% | 0.00% | -100.0% |
| Q1 2018 | $192,000 | -72.8% | 3,627 | -65.1% | 0.00% | -50.0% |
| Q4 2017 | $706,000 | -26.9% | 10,379 | -11.5% | 0.00% | -33.3% |
| Q3 2017 | $966,000 | -15.7% | 11,728 | -4.2% | 0.00% | -40.0% |
| Q2 2017 | $1,146,000 | +282.0% | 12,239 | +159.9% | 0.01% | +400.0% |
| Q1 2017 | $300,000 | -8.8% | 4,710 | -36.4% | 0.00% | -50.0% |
| Q4 2016 | $329,000 | +585.4% | 7,400 | +453.1% | 0.00% | – |
| Q3 2016 | $48,000 | – | 1,338 | +12063.6% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 11 | -99.9% | 0.00% | -100.0% |
| Q3 2015 | $1,266,000 | – | 13,778 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |